10x Genomics Inc (GB:0A88)

10x Genomics (0A88) Stock Price & Analysis


0A88 Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$24.34 - $57.90
Previous Close$53.16
Average Volume (3M)433.00
Market Cap
Enterprise Value$5.83B
Total Cash (Recent Filing)$420.79M
Total Debt (Recent Filing)$102.04M
Price to Earnings (P/E)N/A
Aug 02, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
Shares OutstandingN/A
10 Day Avg. Volume67
30 Day Avg. Volume433
Standard DeviationN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/Revenue10.86
Enterprise Value/Gross Profit14.71
Enterprise Value/Ebitda-40.91
Price Target Upside21.57% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8



0A88 FAQ

What was 10x Genomics Inc’s price range in the past 12 months?
10x Genomics Inc lowest stock price was $24.34 and its highest was $57.90 in the past 12 months.
    What is 10x Genomics Inc’s market cap?
    Currently, no data Available
    When is 10x Genomics Inc’s upcoming earnings report date?
    10x Genomics Inc’s upcoming earnings report date is Aug 02, 2023 which is in 63 days.
      How were 10x Genomics Inc’s earnings last quarter?
      10x Genomics Inc released its earnings results on May 03, 2023. The company reported -$0.44 earnings per share for the quarter, missing the consensus estimate of -$0.375 by -$0.065.
        Is 10x Genomics Inc overvalued?
        According to Wall Street analysts 10x Genomics Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does 10x Genomics Inc pay dividends?
          10x Genomics Inc does not currently pay dividends.
          What is 10x Genomics Inc’s EPS estimate?
          10x Genomics Inc’s EPS estimate is -$0.4.
            How many shares outstanding does 10x Genomics Inc have?
            Currently, no data Available
            What happened to 10x Genomics Inc’s price movement after its last earnings report?
            10x Genomics Inc reported an EPS of -$0.44 in its last earnings report, missing expectations of -$0.375. Following the earnings report the stock price went same 0%.
              Which hedge fund is a major shareholder of 10x Genomics Inc?
              Among the largest hedge funds holding 10x Genomics Inc’s share is ARK Investment Management LLC. It holds 10x Genomics Inc’s shares valued at 232M.


                10x Genomics Stock Smart Score

                The 10x Genomics Holdings stock analysis is based on the TipRanks Smart Score which is derived from 6 unique data sets including Analyst recommendations, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                Learn more about TipRanks Smart Score

                Company Description

                10x Genomics Inc

                10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company's products include Single Cell Gene Expression, Immune Profiling, CNV, ATAC, and Genome and Exome. 10X Genomics was founded by Serge Saxonov, Ben Hindson, Kevin D. Ness and Eduard Diviu Terradas on July 2, 2012 and is headquartered in Pleasanton, CA.


                Forecast EPS vs Actual EPS

                Similar Stocks
                Price & Change
                Medpace Holdings
                10x Genomics

                Popular Stocks

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis